Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Choose Your Experience

Over 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

5/24/2024
BiosimilarsBreakingRegulationRetina
US FDA Approves First Interchangeable Biosimilars to Eylea
US FDA Approves First Interchangeable Biosimilars to Eylea

The FDA announced May 20 that it had approved the US’ first interchangeable biosimilars to Eylea (aflibercept)— Yesafili, from India’s Biocon Biologics, and Opuviz, which was jointly developed by B...

5/24/2024
BiosimilarsBreakingDry EyeGlaucomaLaserRetinaRevenue
Q1-2024 Ophthalmic Revenue Roundup for AbbVie, Iridex, and Biogen
Q1-2024 Ophthalmic Revenue Roundup for AbbVie, Iridex, and Biogen

AbbVie, of North Chicago, Illinois, reported April 26 that its Q1-2024 eye care net revenue totaled $538 million, an 11.7 percent decline (-10.4 percent cc) from $608 million in Q1-2023. Restasis r...

5/24/2024
BreakingGlaucomaRegulationSurgical
New World Medical Gains US 510(k) Clearance for Kahook Dual Blade Glide
New World Medical Gains US 510(k) Clearance for Kahook Dual Blade Glide

New World Medical reported May 22 that its Kahook Dual Blade Glide had gained US FDA 510(k) clearance. The goniotomy device is designed to excise trabecular meshwork tissue to reduce intraocular pr...

5/22/2024
CataractMeetingNewsletterRetinaSurgical
Champalimaud Vision Award Recognizes Eye Hospital Serving Gaza and West Bank
Champalimaud Vision Award Recognizes  Eye Hospital Serving Gaza and West Bank

A sparsely attended Champalimaud Vision Award Lecture at the 2024 ARVO meeting highlighted the work of St. John of Jerusalem Eye Hospital in Gaza, Jerusalem, and the West Bank. Leonor Beleza, presi...

5/24/2024
BreakingDiagnosticGlaucoma
Reichert Launches Tono-Vera Hand-held Tonometer in US
Reichert Launches Tono-Vera Hand-held Tonometer in US

Reichert announced May 6 that its Tono-Vera hand-held tonometer is now available in the US. Tono-Vera provides quick, automated, and reliable intraocular pressure measurements with rebound tonomete...

5/24/2024
BreakingClinical TrialRegulationRetina
US FDA Gives Green Light to Phase Ib Trial of Drug Farm’s Oral ALPK1 Inhibitor in ROSAH Patients
US FDA Gives Green Light to Phase Ib Trial of Drug Farm’s Oral ALPK1 Inhibitor in ROSAH Patients

Drug Farm, of Shanghai, China, announced May 17 that the US FDA had cleared its investigational new drug (IND) application for a Phase Ib trial of its DF-003, an oral alpha kinase 1 (ALPK1) inhibit...

5/24/2024
BreakingCOVID-19Study
Researchers at MU Find COVID-19 Virus Crosses Blood-Retinal Barrier
Researchers at MU Find COVID-19 Virus Crosses Blood-Retinal Barrier

The virus that causes COVID-19 can breach the blood-retinal barrier, with potential long-term consequences for eye health, researchers at the University of Missouri School of Medicine have discover...

5/24/2024
BreakingChinaRegulation
Chinese Regulators Accept NDA from Innovent for IBI311 in Thyroid Eye Disease
Chinese Regulators Accept NDA from Innovent for IBI311 in Thyroid Eye Disease

China’s Innovent Biologics announced May 20 that Chinese regulators had accepted the new drug application for IBI311, a recombinant anti-insulin-like growth factor 1 receptor antibody for thyroid e...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

Select your country...